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Abstract
Background: A major requirement for malaria elimination is the development of transmission-blocking interventions.
In vitro transmission-blocking bioassays currently mostly rely on the use of very few Plasmodium falciparum reference
laboratory strains isolated decades ago. To fill a piece of the gap between laboratory experimental models and natural
systems, the purpose of this work was to determine if culture-adapted field isolates of P. falciparum are suitable for
in vitro transmission-blocking bioassays targeting functional maturity of male gametocytes: exflagellation.
Methods: Plasmodium falciparum isolates were adapted to in vitro culture before being used for in vitro gametocyte
production. Maturation was assessed by microscopic observation of gametocyte morphology over time of culture and
the functional viability of male gametocytes was assessed by microscopic counting of exflagellating gametocytes.
Suitability for in vitro exflagellation-blocking bioassays was determined using dihydroartemisinin and methylene blue.
Results: In vitro gametocyte production was achieved using two isolates from French Guiana and two isolates from
Cambodia. Functional maturity of male gametocytes was assessed by exflagellation observations and all four isolates
could be used in exflagellation-blocking bioassays with adequate response to methylene blue and dihydroartemisinin.
Conclusion: This work shows that in vitro culture-adapted P. falciparum field isolates of different genetic background,
from South America and Southeast Asia, can successfully be used for bioassays targeting the male gametocyte to
gamete transition, exflagellation.
Background
Among the actions required for malaria elimination,
blocking the transmission of Plasmodium parasites from
human to mosquitoes is critical [1]. Passage through the
vector is an obligatory step for the parasite to continue
its life cycle and it relies exclusively on the most mature
forms of the sexual stages, stage V gametocytes. Mosquito
feeding assays remain the gold standard to evaluate
transmission-blocking strategies but require resource-
intensive techniques. To circumvent these technical diffi-
culties, several in vitro transmission-blocking bioassays
targeting the sexual stages of the parasite have been de-
scribed with different endpoints and various interpretative
values [2, 3]. Although the outputs of these in vitro assays
are difficult to transpose in vivo, the most clinically rele-
vant assay should be able to evaluate the ability of a
compound to either kill stage V gametocytes (viability
assay) or inhibit their ability to differentiate into later
mosquito stages (functional maturity assay). It is possible
to induce in vitro gamete formation from Plasmodium
falciparum male and female gametocytes where male
gametocytes undergo major differentiation leading to
the production of eight mobile gametes, by a process
called exflagellation, which is easily observed visually.
Currently, the majority of P. falciparum in vitro
transmission-blocking studies use a handful of reference
laboratory strains, isolated decades ago. While these
strains are useful to normalize high throughput screen-
ings, results should be verified on natural parasites that
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have been selected after years of multiple drug exposures
and hence are likely to display differential drug responses
compared to reference strains. In addition, it is well
known that gametocyte production capacity is lost over
time of in vitro culture [2, 4]. Laboratories must therefore
rely on precious stocks of cryopreserved isolates with min-
imal passage since in culture. Adaptation of P. falciparum
isolates from patients to in vitro blood-stage culture is
routinely performed. Studies describing the use of field
isolates for in vitro gametocyte cultures have been pub-
lished in the early 1980s and have led to the selection of
the current reference strains [4–8]. Nowadays using circu-
lating parasites after culture adaptation for transmission-
blocking assay is rarely performed. Some studies have
shown that they can be used in gametocyte viability assay
[9] or for experimental infections of mosquitoes [10], how-
ever their use for exflagellation-blocking bioassays, report-
ing in vitro functional maturity of gametocytes has not
been reported yet. A requirement for their use in such
assay is to be able to produce functional gametocytes in
high enough number to be meaningful in a bioassay.
The objective of the work presented here was there-
fore to determine if culture-adapted field isolates could
be used for recently developed in vitro exflagellation-
blocking bioassays [11].
Methods
Reference strain and field isolates
The P. falciparum South American chloroquine-resistant
strain 7G8 (MRA-926) has been obtained from the MR4.
Plasmodium falciparum isolates were collected from mono-
infected patients seeking treatment in 2013 in French
Guiana (Q206 and Q188) and in 2014 in Cambodia (6831
and 6836).
In vitro culture adaptation
Culture adaptation of isolates was performed using standard
protocols [12, 13]. Briefly, after removal of plasma, the red
blood cell (RBC) pellet was washed three times in RPMI
1640 supplemented with gentamicin (Gibco-Life Technolo-
gies SAS, France) and placed in culture medium (RPMI
1640, 0.5 % AlbuMAX II (Gibco-Life Technologies SAS,
France), 2 % decomplemented human plasma) at 4 % haem-
atocrit at 37 °C in 5 or 10 % O2, 5 % CO2, rest of N2 atmos-
phere. Parasitaemia was checked daily and kept below 2 %
by dilutions with fresh RBC and medium. Field isolates were
considered adapted to in vitro conditions after three weeks
of uninterrupted culture. After culture adaptation, asexual
blood-stage sensitivity to anti-malarials was determined
using the [3H]-hypoxanthine incorporation assay [14].
In vitro gametocyte production and maturation
Gametocyte cultures were performed following pub-
lished protocols [2, 11]. Briefly, asexual cultures with a
parasitaemia of ~5 % were used to seed gametocyte
cultures at 0.5–1 % parasitaemia and 4 % haematocrit
under 5 or 10 % O2, 5 % CO2, rest of N2 atmosphere.
Culture medium (RPMI medium with 25 mM HEPES,
50 mg/L hypoxanthine, 2 g/L sodium bicarbonate, 10 %
human serum) was replaced daily but without any
further addition of RBCs and critically, temperature was
maintained at all time at 37 °C.
Gametocytogenesis was evaluated morphologically
using Giemsa-stained blood films. Stage V male gameto-
cyte functional maturity was assessed by observation of
exflagellation in wet preparation under bright-field micro-
scope. A 30-μL aliquot of gametocyte culture was briefly
centrifuged, the cell pellet was resuspended in 15 μL of
ookinete medium (RPMI medium with 25 mM HEPES,
50 mg/L hypoxanthine, 2 g/L sodium bicarbonate, 100 μM
xanthurenic acid, 10 % human serum) and then introduced
into a chamber of a FastRead disposable haemocytometer
slide (Immune Systems). Exflagellation centres were
observed at 10 × or 20 × magnification.
Exflagellation-blocking bioassay
Exflagellation-blocking assays were performed according
to published protocols [11]. Assays were performed using
gametocyte cultures providing high enough exflagellation
centres for meaningful measures (>30 in five 10 × micros-
copy fields).
To show the suitability of field isolates for exflagellation-
blocking assays, the activity of 1 μM of dihydroartemisinin
(DHA), methylene blue (MeBlue) and chloroquine (CQ)
was evaluated. Assays were carried out in 1.5-mL tubes
containing 170 μL of gametocyte culture medium with
1 μM of drugs dissolved in either DMSO or methanol.
Thirty μL of stage V mature gametocyte was dispensed
into each assay tube. Tubes were then placed into a 37 °C
incubator. After 24 h, exflagellation was induced by
temperature drop to 25 °C and replacing culture medium
with ookinete medium. The number of exflagellation cen-
tres were recorded and compared to controls (DMSO or
methanol). Activity was expressed as percentage of exfla-
gellation inhibition compared to controls.
Results
The protocols were first optimized by using the South
American isolates prior to being verified with the Southeast
Asian isolates. Gametocyte development was straight-
forward at the first attempt. Initially however, although
stage V gametocytes were clearly identified in the cul-
tures, no exflagellation was observed. This suggests that
bioassays with a read-out based only on morphological
development of gametocytes do not report on their
onward functional viability, therefore they may be
underpowered. As already observed by others [2, 4], the
age of uninfected RBC when initiating the gametocyte
Leba et al. Malaria Journal  (2015) 14:234 Page 2 of 4
culture was a critical factor for successful maturation: RBC
stored at 4 °C more than ~ two to 3 days rapidly comprom-
ise maturation. Additionally, variability in human serum
was found also to be a critical point for gametocyte matur-
ation, so pools from different donors of serum were used
when possible. Using fresh uninfected RBC, fully mature
gametocytes capable of exflagellation were generated for all
isolates. For all isolates and 7G8, gametocyte development
time was similar and maturity peaked at ~16–18 days of
culture, slightly longer than what is usually reported for
3D7, ~12–14 days (Fig. 1) [2, 11].
It is important to note that all the experiments using
7G8 and the South American isolates were performed in
a different laboratory (Institut Pasteur de la Guyane,
Cayenne) than those using the Cambodian isolates
(Institut Pasteur du Cambodge, Phnom Penh) showing
good reproducibility in the protocols that can be easily
implemented in laboratories doing P. falciparum in vitro
culture adaptation.
Exflagellation is a time-dependent process [15]. Within
20 min after induction, for all field isolates and the refer-
ence strain 7G8, a plateau is reached allowing consistent
measurements for ~10 min (Fig. 2). This is similar to
what has previously been observed with 3D7 [11].
Although the patterns of gametocyte development and
time for exflagellation are similar for all isolates and labo-
ratory strains, there are variations in the amount of
exflagellation centres from one isolate to another (see
Additional file 1) as already observed by others [4]. For
example, in French Guiana, the isolate Q206 consist-
ently gave higher number of exflagellation than Q188.
Nevertheless, for all the isolates, using gametocyte
cultures at maturity, the numbers of exflagellation cen-
tres obtained were high enough to allow significant
measures in exflagellation-blocking bioassay (from ~35
to >100, see Additional file 1).
Based on those observations, a previously described
exflagellation-blocking protocol was adapted to the four
field isolates and 7G8 [11]. Exflagellation centres were
recorded between 20 and 30 min after induction of
18 days-old gametocyte cultures. As a proof-of-concept,
the activity of DHA and MeBlue was evaluated as both
compounds have been previously reported to block
exflagellation of 3D7 [11]. As negative control, CQ was
used on a sub-set of the strains [16]. Mature gameto-
cytes were incubated 24 h in presence of 1 μM of each
drug before exflagellation was induced. All isolates
responded similarly to the compounds with 1 μM DHA
giving 78–99 % inhibition and consistently near total in-
hibition with 1 μM of MeBlue (Table 1). As expected,
CQ had no effect on exflagellation in any isolate tested.
Fig. 1 Exflagellation levels over days of gametocyte culture (arbitrary
unit). For each independent culture, exflagellation centres values are
normalized to the highest value of the culture (data are presented in
Additional file 1). The mean and SEM of three cultures is shown for
7G8 and the two French Guiana strains (Q188 and Q206) while a single
culture for each Cambodian isolate is represented (6831 and 6836)
Fig. 2 Exflagellation levels over time after temperature drop and
addition of xanthurenic acid of gametocyte cultures (arbitrary unit).
For each independent culture, exflagellation centres values are
normalized to the highest value of the culture (data are presented
in Additional file 1). The mean and SEM of two independent culture is
shown for the two French Guiana strains (Q188 and Q206) while a
single culture for the Cambodian isolate (6836) and the reference strain
7G8 are represented
Table 1 Exflagellation-blocking activitya of dihydroartemisinin
(DHA), methylene blue (MeBlue) and chloroquine (CQ) against
Plasmodium falciparum field isolates and the 7G8 reference strain
7G8 Q188 Q206 6831 6836
DHA 99 ± 1.3 90 ± 8.3 78 ± 7.2 84 ± 12.2 79 ± 11.6
MeBlue 100 100 99 ± 1.7 100 99 ± 2.1
CQ −1 ± 10.8 ND 5.7 ± 10.2 ND 7.3 ± 19.2
aExpressed as a percentage of inhibition compared to the drug-free control
(mean ± SEM, n = 3)
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Conclusion
This work reports that freshly culture-adapted field iso-
lates, from various geographical origins and genetic
background can produce functionally mature gameto-
cytes in vitro in high enough numbers to be successfully
used in exflagellation-blocking bioassays. Moreover, the
assay was sensitive enough to observe inter-strain dif-
ferences, which might be of significant interest for com-
prehension of malaria transmission in the field. Indeed,
the Q188 isolate is chloroquine-sensitive (IC50 = 34.93
nM ± 1.91) and consistently produced fewer gameto-
cytes in vitro than the Q206 isolate that is chloroquine-
resistant (IC50 = 483.36 nM ± 61.25). Of course, given
the low number of isolates, no conclusion can be drawn
based on this work and further studies are required to
evaluate a possible link between chemosensitivity and
in vitro gametocytogenesis. In addition, at least one
cryopreservation cycle did not impair the capacity of
the field isolates in producing mature gametocytes.
However, for how long in culture this capacity will be
maintained before being lost, as expected remains to be
evaluated. Finally, the infectivity to mosquitoes of the
mature gametocytes should be assessed to transpose the
in vitro results to an in vivo model of transmission.
Capacity building for experimental infections of mos-
quitoes is currently being undergone in Institut Pasteur,
both in French Guiana and in Cambodia, and will allow
such experiments in a near future.
Additional file
Additional file 1: Absolute and normalized exflagellation values.
Dataset including exflagellation values over days of culture and exflagellation
values over time after induction.
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